Hepatocellular carcinoma (HCC) accounts for about 90% of all primary liver cancers and is
the second leading cause of cancer-related deaths worldwide. The hypervascular nature of …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated death
worldwide. Angiogenesis, the process of formation of new blood vessels, is required for …

Hepatocellular carcinoma (HCC) is a hypervascular tumor characterized by
neovascularization, which plays an important role in the growth and progression of HCC …

Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide, usually
occurring on a background of liver cirrhosis. HCC is a highly vascular tumor in which …

Hepatocellular carcinoma (HCC) is one of the most vascular solid tumors, in which
angiogenesis plays an important role. The status of angiogenesis in HCC correlates with the …

Hepatocellular carcinoma (HCC) is a typical hypervascular tumor. Many angiogenic factors
have been studied in HCC, and several anti-angiogenic therapies have been tested in …

Hepatocellular carcinoma (HCC), the most common primary liver tumor, is notoriously
resistant to systemic therapies, and often recurs even after aggressive local therapies. HCCs …

Solid tumors constantly require a vascular supply for their progression and metastasis.
Hepatocellular carcinoma (HCC) is known to gain its hypervascularity during the process of …

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and
one of the few malignancies with an increasing incidence in the USA. While the relationship …

Background: Angiogenesis inhibitors have become an important therapeutic approach in the
treatment of hepatocellular carcinoma (HCC) patients. The therapeutic inhibition of …